Workflow
潜江永安药业股份有限公司关于全资子公司 通过高新技术企业重新认定的公告

Group 1 - The company, Yong'an Pharmaceutical, announced that its wholly-owned subsidiary, Yong'an Kangjian Pharmaceutical (Wuhan) Co., Ltd., has successfully passed the re-certification as a high-tech enterprise [1] - The re-certification was issued by the Hubei Provincial Department of Science and Technology, Hubei Provincial Department of Finance, and the State Taxation Administration of Hubei Province, with the certificate number GR202442005101 and a validity period of three years [1] - Following the re-certification, Yong'an Kangjian will continue to enjoy tax benefits under the high-tech enterprise policy, specifically a corporate income tax rate of 15% for the years 2024, 2025, and 2026 [1] Group 2 - The company has already filed tax returns and prepayments based on the 15% corporate income tax rate, and the re-certification does not affect previously disclosed financial data [1]